Jeremy W Mason

Title: Jeremy W Mason - Innovator in Therapeutic Compounds

Introduction

Jeremy W Mason is a notable inventor based in Sarnia, Canada. He has made significant contributions to the field of therapeutic agents, particularly in the synthesis of compounds aimed at combating emerging flu strains. His innovative work has the potential to minimize resistance to these strains, showcasing his dedication to advancing medical science.

Latest Patents

Jeremy W Mason holds a patent for the "Synthesis of bicyclic compounds and method for their use as therapeutic agents." This patent discloses embodiments concerning the synthesis and use of therapeutic compounds that are effective in treating emerging flu strains. The methods outlined in the patent involve a base-mediated addition/cyclization sequence followed by functional group manipulation. This process allows for the development of functionalized compounds that can effectively target neuraminidase, making them ideal candidates for influenza treatment. Additionally, the patent describes pharmaceutical compositions comprising these therapeutic compounds and biologically acceptable materials. Methods for inhibiting neuraminidase in subjects suspected of containing this enzyme are also included. Furthermore, the use of metabolites of the disclosed compounds can be utilized in diagnostic assays for therapeutic dosing.

Career Highlights

Jeremy W Mason is associated with Uvic Industry Partnerships Inc., where he continues to contribute to innovative research and development. His work in this organization highlights his commitment to translating scientific discoveries into practical applications that can benefit public health.

Collaborations

Some of Jeremy's coworkers include Caleb M Bromba and Michael G Brant. Their collaboration reflects a team-oriented approach to research and innovation, fostering an environment where groundbreaking ideas can flourish.

Conclusion

Jeremy W Mason is a distinguished inventor whose work in therapeutic compounds is paving the way for advancements in influenza treatment. His patent and ongoing contributions to Uvic Industry Partnerships Inc. exemplify his commitment to innovation in the medical field.